Study title: "Calello DP, Osterhoudt KC, Henretig FM.New and novel antidotes in pediatrics.Pediatr Emerg Care. 2006 Jul;22(7):523-30. Review. Erratum in: Pediatr Emerg Care. 2007 Feb;23(2):82. " "Calello DP, Osterhoudt KC, Henretig FM.New and novel antidotes in pediatrics.Pediatr Emerg Care. 2006 Jul;22(7):523-30. Review. Erratum in: Pediatr Emerg Care. 2007 Feb;23(2):82. "
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Disorders of Environmental Origin [C21] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: FOMEPIZOLE | |||||
ATC code: V03AB34 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |